Bioinformatics Markets: Genomic Sequencing, Drug Design &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bioinformatics Markets: Genomic Sequencing, Drug Design & Proteomics - Global Market Size, Strategy and Forecasts - 2016 to 2020

Dublin, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/2x...nformatics ) has announced the addition of the "Bioinformatics Markets - Global Market Size, Strategy and Forecasts - 2016 to 2020" report to their offering. This new Bioinformatics sector of the biotechnology industry is poised for record growth. New technologies, people and services will be needed to help interpret the meaning of genetic information: for people, for animals and for plants. It is creating new opportunities for the next stage of the genomics revolution where information analysis and data processing technologies take the spotlight.

The market is still in its infancy but has outstanding growth potential. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country. The report includes detailed breakouts for 18 Market Segments. Genomic Sequencing? Drug Design? Proteomics? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. Key Topics Covered: 1. Introduction and Market Definition 1.1 What is Bioinformatics? 1.2 The Genetics Revolution 1.3 Market Definition 2. Market Overview 2.1 Market Participants 2.2 Bioinformatics Technology Overview 3. The Bioinformatics Market 3.1 Market Segmentation Discussion 3.2 End User Segments 3.3 Product Segments 3.4 Application Segments 4. Profiles of Key Bioinformatics Companies 4.1 Affymetrix, Inc. 4.2 Agena Bioscience, Inc. 4.3 Agilent Technologies 4.4 Applied Biological Materials 4.5 Biomax Informatics AG 4.6 Dassault Systemes 4.7 Dnanexus, Inc. 4.8 Geneva Bioinformatics (Genebio) SA 4.9 ID Business Solutions Ltd. 4.10 Instem, PLC 4.11 Illumina, Inc. 4.12 Integromics S.L. 4.13 Qiagen 4.14 Non Linear Dynamics Ltd. 4.15 Perkinelmer, Inc. 5. Market Issues and Trends 5.1 Factors Driving Growth 5.2 Factors Limiting Growth 5.3 The Genetic Information Puzzle - The Heart of Bioinformatics 5.4 Biotechnology Development 6. Bioinformatics Recent Developments 6.1 Recent Developments - Importance and How to Use This Section 6.2 Agilent Technologies backs new life science research center at Carleton University 6.3 WuXi PharmaTech Announces Third-Quarter 2015 Results 6.4 Ceres Announces KWS to Evaluate Bioinformatics Technology 6.5 Qiagen Announces Launch of New Bioinformatics Solution for Hereditary Diseases 6.6 Computer Sciences Will Combine CSGov Unit with SRA 6.7 NeoGenomics to Acquire GE's Clarient in Cash, Stock Deal 6.8 OpGen to Acquire AdvanDx, Inc. 6.9 CollabRx, Medytox Reach Merger Agreement 6.10 MediSapiens Ltd Introduces Bioinformatics Solution 6.11 Bioinformatics Startup Computomics Raises 500,000 6.12 FDA starts beta-testing 'the most advanced bioinformatics platform in the world' 6.13 Genomenon breaks through bioinformatics bottleneck 6.14 MediSapiens Introduces Bioinformatics Solution 6.15 AstraZeneca commits $18M to clinical trial bioinformatics collaboration 6.16 Selvita Spins Out Bioinformatics Business Into Subsidiary Ardigen 6.17 Deep Genomics Launches First Product for Bioinformatics Market 6.18 SCIEX Announces Exclusive Reseller Agreement with Advaita Bioinformatics 6.19 New Standard for Sharing Bioinformatics Tools and Workflows 6.20 Vermillion raises $18.8M to fund escalation of bioinformatics ambitions 6.21 Aeon Clinical Laboratories Leverages PierianDx Bioinformatics Platform to Enhance Genomic Test Offering 6.22 Bioinformatics tool rapidly verifies prostate cancer biomarkers 6.23 Broad Institute, Google Genomics combine bioinformatics and computing 6.24 MedBioinformatics project receives 3.5 million euros in funding 6.25 Genome Canada Announces $11 million in New Funding 6.26 Rosetta Genomics Reports Third Quarter 2015 Financial Results 6.27 UT Southwestern snags $5.6M grant to boost bioinformatics 6.28 Molecular Diagnostics Laboratories Partners with PierianDx 6.29 LifeMap Sciences' Bioinformatics Tools Licensed by SciLifeLab 7. Market Sizes, Forecasts & Growth Rates - Sectors 7.1 Medical 7.2 Agriculture 7.3 Academic and Research Markets 7.4 Other 8. Market Sizes, Forecasts & Growth Rates - Products 8.1 Instrumentation 8.2 Content Management 8.3 Bioinformatics Services 9. Market Sizes, Forecasts & Growth Rates - Applications 9.1 Applications 10. Global Market Summary 10.1 Global 10.2 Potential Market Opportunity Sizes 10.3 Potential Market Sizes by Country Selected Segments Companies Mentioned - Advaita Bioinformatics - AdvanDx, Inc. - Aeon Clinical Laboratories - Affymetrix, Inc. - Agena Bioscience, Inc. - Agilent Technologies - Applied Biological Materials - Ardigen - AstraZeneca - Biomax Informatics AG - Broad Institute - Ceres - Clarient Inc - CollabRx - Computomics - Dassault Systemes - Dnanexus, Inc. - Geneva Bioinformatics (Genebio) SA - Genome Canada - Genomenon - Google - ID Business Solutions Ltd. - Illumina, Inc. - Instem, PLC - Integromics S.L. - LifeMap Sciences - MedBioinformatics - MediSapiens Ltd - Medytox - NeoGenomics - Non Linear Dynamics Ltd. - OpGen - Perkinelmer, Inc. - PierianDx - Qiagen - Rosetta Genomics - SCIEX - SciLifeLab - Selvita - UT Southwestern - Vermillion - WuXi PharmaTech For more information visit http://www.researchandmarkets.com/research/2x...nformatics

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Bioinformatics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 5

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Nike and Resources Connection Performance Insights

Updated Category News Views 48

Understanding Market Movements After Earnings Reports In the dynamic world of stock trading, after-hours performance can tell investors a lot about how companies are faring with their earnings announcements. Recently, notable corporations like Nike and Resources Connection saw significant stock movements in reaction to their quarterly earnings, stirring interest among...

Continue Reading
Heartwood Partners Completes Successful Sale of Sur-Seal

Updated Category News Views 258

Heartwood Partners Completes Sale of Sur-Seal Heartwood Partners is excited to share that Heartwood Partners III, LP and its affiliates have finalized the sale of Sur-Seal, LLC to Brodie Generational Capital Partners, an investment firm with a focus on long-term commitments to industrial companies. This marks an important milestone in Heartwood's expansive history. About...

Continue Reading
Geneoscopy Secures $105M Funding to Transform Diagnostics

Updated Category News Views 242

Geneoscopy Completes Series C Funding for Gastrointestinal Health Geneoscopy, Inc., a prominent life sciences company dedicated to enhancing gastrointestinal health through innovative diagnostic tests, has recently finalized a Series C funding round that garnered an impressive $105 million. This strategic investment, spearheaded by Bio-Rad Laboratories, not only bolsters...

Continue Reading
AIM ImmunoTech Invites Shareholders to Support Current Board

Updated Category News Views 82

AIM ImmunoTech Encourages Shareholder Participation AIM ImmunoTech Inc. (NYSE American: AIM) is calling on its valued shareholders to actively participate in an important upcoming event. With the 2024 Annual Meeting of Stockholders on the horizon, AIM is reminding everyone to make their voices heard by voting 'FOR' the incumbent members of its Board of Directors. Why...

Continue Reading
Understanding Short Interest Trends for Thermo Fisher Scientific

Updated Category News Views 148

Understanding Short Interest in Thermo Fisher Scientific Inc Thermo Fisher Scientific Inc (NYSE: TMO) has seen a notable increase in its short interest, which has risen by 10.78% since the last report. Recent data indicates that 4.27 million shares have been sold short, representing 1.13% of the total shares available for trading. Analyzing the trading volume, it appears...

Continue Reading